Best Brian Steffen Podcasts (2024)

1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology TRANSCRIPT

3h ago

—

Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…

1
Menin Inhibition Shows Potential for Precision Therapy in AML with Dr. Mollie Leoni Kura Oncology 18:16

3h ago18:16

18:16

Dr. Mollie Leoni, Executive Vice President for Clinical Development of Kura Oncology, discusses the company's ziftomenib program, a menin inhibitor for acute myeloid leukemia (AML). The company initially allowed all AML patients to participate in the clinical study, but later found that specific subtypes, such as those with NPM1 mutation or KMT2A r…

1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma TRANSCRIPT

2h ago

—

Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …

1
New Landscape for Controlling Obesity and Lowering Incidence of Related Diseases with Dr. Steffen-Sebastian Bolz Aphaia Pharma 21:01

2h ago21:01

21:01

Dr. Steffen-Sebastian Bolz, Chief Scientific Officer of Swiss-based Aphaia Pharma, shines a light on the excitement around weight loss drugs due to the discovery that GLP-1 agonists and points out the shift in the perception of obesity as a root cause of various health issues. Aphaia Pharma's approach involves stimulating hormone production in the …

1
2025 Worlds qualification speculation and wishlist 1:07:04

23h ago1:07:04

1:07:04

0:00 Intros 1:20 Regional Changes 30:00 Invite Changes 51:00 Location dreams Bean: https://x.com/mrdarthbean Loc: https://x.com/Da_L0c Twitter: https://twitter.com/Mellow_Magikarp Podcast: https://twitter.com/LakeOfRagepod Discord: https://discord.gg/SmbccF55xZ Twitch: https://www.twitch.tv/mellow_magikarp Sponsor: https://www.tabletopvillage.com/ …

1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health TRANSCRIPT

4h ago

—

Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…

1
Healthcare Outcomes When Hospitals Embrace Vertical Farming with Rick Vanzura Freight Farms and Dr. Amber Orman Advent Health 22:28

4h ago22:28

22:28

Rick Vanzura, CEO of Freight Farms, and Dr. Amber Orman, Chief Wellness Officer at Advent Health, discuss their partnership in bringing hyperlocal, sustainable food to healthcare facilities. Freight Farms uses modified shipping containers to grow crops, allowing for year-round production with minimal land and water usage. Advent Health recognized t…

1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation TRANSCRIPT

1h ago

—

Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…

1
Advancements in Gene Therapy for Rare Ocular Disease and Metabolic Disorders with Guang Qu NGGT Corporation 21:45

1h ago21:45

21:45

Guang Qu, Co-Founder of NGGT Corporation is focused on developing gene therapy products using dual functional vector strategies. Guang highlights the importance of distinguishing between recessive and dominant mutations in rare diseases and explains how their approach differs from other gene therapy approaches. The two leading indications caused by…

1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis TRANSCRIPT

20h ago

—

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…

1
New Scaffold for Treating Severe Peripheral Artery Disease Below the Knee with Jennifer Jones-McMeans Abbott and Dr. Brian DeRubertis 22:08

20h ago22:08

22:08

Jennifer Jones-McMeans, divisional vice president of global clinical affairs at Abbott’s vascular business, and Dr. Brian DeRubertis, a doctor at the New York-Presbyterian Weill Cornell Medical Center, shine a light on peripheral artery disease and critical limb-threatening ischemia where artery blockage restricts blood flow to the lower legs. Abbo…

1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines TRANSCRIPT

2d ago

—

Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …

1
Developing Essential Tremor and Other CNS Therapies with Marcio Souza Praxis Precision Medicines 19:10

2d ago19:10

19:10

Marcio Souza, President and CEO of Praxis Precision Medicines, discusses the challenges in treating central nervous system disorders and is focused on developing life-altering treatments for patients with essential tremor. Current treatments for epilepsy are often broad-based and not specific to the underlying cause of the disease. Praxis is using …

1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies TRANSCRIPT

3d ago

—

Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…

1
Driving Interoperability and Ubiquitous Access to Healthcare Information with Dr. John Blair MedAllies 21:15

8d ago21:15

21:15

Dr. John Blair, CEO of MedAllies, was created to address the lack of communication and coordination between healthcare providers and the importance of interoperability in healthcare. While healthcare has become more complicated over the years, with advancements in technology and automation, the lack of reimbursement for coordination of care has con…

1
Top 16 Regidrago interview with Jacob Eye 43:22

3d ago43:22

43:22

0:00 Intros2:20 Rapid Strike Questions5:30 NAIC prep11:00 Match-ups20:00 DecklistJacob: https://x.com/jacobe64608601Twitter: https://twitter.com/Mellow_MagikarpPodcast: https://twitter.com/LakeOfRagepodDiscord: https://discord.gg/SmbccF55xZTwitch: https://www.twitch.tv/mellow_magikarpSponsor: https://www.tabletopvillage.com/Code: Mellow5 for 5% off…

1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics TRANSCRIPT

8d ago

—

Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…

1
Universal Approach to Cell Therapy Using SNAP-CAR with Dave Mehalick Coeptis Therapeutics 19:11

8d ago19:11

19:11

Dave Mehalick, Chairman, Co-Founder, President, and CEO of Coeptis Therapeutics, focuses on developing cell therapies for oncology and respiratory diseases. They aim to create a universal cell therapy that can be used for various types of cancer and move it from a later line of treatment to a frontline therapy. The company has developed a unique CA…

1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC TRANSCRIPT

9d ago

—

Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …

1
Unlocking the Power of CRISPR Technology for Drug Development with Ross Bundy CRISPR QC 19:27

9d ago19:27

19:27

Ross Bundy, President and CEO of CRISPR QC, shines a light on the current state of CRISPR gene editing technology and how the field has advanced rapidly since the discovery of CRISPR's potential to edit the human genome. The focus of CRISPR technology has primarily been on curing rare and genetic diseases, but there is also potential for targeting …

1
Therapeutic Cancer Vaccines with Nicolas Poirier OSE Immunotherapeutics TRANSCRIPT

10d ago

—

Nicolas Poirier, CEO of OSE Immunotherapeutics, uses immunology and molecular engineering to develop innovative immunotherapies for oncology, inflammation, autoimmune diseases, and organ transplant. The same immune cells, lymphocytes and macrophages, are involved in both immuno-oncology and immuno-inflammation, and OSE aims to re-educate these cell…

1
Therapeutic Cancer Vaccines with Nicolas Poirier OSE Immunotherapeutics 20:17

10d ago20:17

20:17

Nicolas Poirier, CEO of OSE Immunotherapeutics, uses immunology and molecular engineering to develop innovative immunotherapies for oncology, inflammation, autoimmune diseases, and organ transplant. The same immune cells, lymphocytes and macrophages, are involved in both immuno-oncology and immuno-inflammation, and OSE aims to re-educate these cell…

1
Innovative Blood Collection Device Boosts Participation in Decentralized Clinical Trials with Ben Casavant Tasso TRANSCRIPT

15d ago

—

Ben Casavant, Co-Founder and CEO of Tasso, focuses on making diagnostics more accessible to patients that allow collection of blood samples at home. Their customers include pharmaceutical companies conducting research and healthcare providers. Using Tasso's technology in decentralized clinical trials allows for easier recruitment, increased patient…

1
Innovative Blood Collection Device Boosts Participation in Decentralized Clinical Trials with Ben Casavant Tasso 19:18

15d ago19:18

19:18

Ben Casavant, Co-Founder and CEO of Tasso, focuses on making diagnostics more accessible to patients that allow collection of blood samples at home. Their customers include pharmaceutical companies conducting research and healthcare providers. Using Tasso's technology in decentralized clinical trials allows for easier recruitment, increased patient…

1
AI-Powered Device Provides Real-Time Screening for Early Detection of Heart Failure Symptoms with Chris Darland Peerbridge Health TRANSCRIPT

17d ago

—

Chris Darland, President and CEO of Peerbridge Health, discusses technology breakthroughs that enable early, low-cost detection of heart issues with a cardiac monitor that uses AI to analyze heart rhythms over time to detect patterns that may indicate heart failure. The device is based on ECG technology that drives the Holter monitor and delivers a…

1
AI-Powered Device Provides Real-Time Screening for Early Detection of Heart Failure Symptoms with Chris Darland Peerbridge Health 19:13

17d ago19:13

19:13

Chris Darland, President and CEO of Peerbridge Health, discusses technology breakthroughs that enable early, low-cost detection of heart issues with a cardiac monitor that uses AI to analyze heart rhythms over time to detect patterns that may indicate heart failure. The device is based on ECG technology that drives the Holter monitor and delivers a…

1
Partnering with Retail Pharmacies to Make Blood Testing More Convenient and Accessible Dr. David Stein Babson Diagnostics TRANSCRIPT

18d ago

—

Dr. David Stein, CEO and Director of Babson Diagnostics, a healthcare technology company that focuses on putting the patient at the center of the blood testing experience, recognizing the importance of blood testing in informing clinical decisions and monitoring health. They aim to redefine blood testing by eliminating the anxiety and inconvenience…

1
Partnering with Retail Pharmacies to Make Blood Testing More Convenient and Accessible Dr. David Stein Babson Diagnostics 17:28

18d ago17:28

17:28

Dr. David Stein, CEO and Director of Babson Diagnostics, a healthcare technology company that focuses on putting the patient at the center of the blood testing experience, recognizing the importance of blood testing in informing clinical decisions and monitoring health. They aim to redefine blood testing by eliminating the anxiety and inconvenience…

1
NAIC Meta Discussion ft. Ian Robb, Michael Chen, Christian Fontenot & Emma Hagen 51:40

17d ago51:40

51:40

0:00 Intros 2:20 Top 3 played decks 8:30 Lugia VSTAR 16:30 Raging Bolt ex 22:00 Gardevoir 29:00 Dragapult 41:00 Snorlax stall 45:00 Best Hands deck Ian: https://x.com/Ian__Robb Michael: https://x.com/Oupas327 Christian: https://x.com/SticksPTCG Emma: https://x.com/Littlesislatias Twitter: https://twitter.com/Mellow_Magikarp Podcast: https://twitter…

1
Impact of AI on Reducing Waste and Friction in Healthcare Administration with Joan Butters Xsolis TRANSCRIPT

22d ago

—

Joan Butters, CEO and Co-Founder of Xsolis works with health systems and health plans to automate medical necessity decisions and improve efficiency. Using data and AI, Xsolis helps clinicians make more informed decisions and reduces manual administrative work, resulting in time and cost savings and improved patient care. Addressing the challenges …

1
Impact of AI on Reducing Waste and Friction in Healthcare Administration with Joan Butters Xsolis 16:07

22d ago16:07

16:07

Joan Butters, CEO and Co-Founder of Xsolis works with health systems and health plans to automate medical necessity decisions and improve efficiency. Using data and AI, Xsolis helps clinicians make more informed decisions and reduces manual administrative work, resulting in time and cost savings and improved patient care. Addressing the challenges …

1
Cancer Molecular Profiling Using Next-Generation Sequencing to Treat Rare Diseases with Sanjeev Redekar Apollomics TRANSCRIPT

23d ago

—

Sanjeev Redkar, Co-Founder, Executive Director, and President of Apollomics, focuses on difficult-to-treat cancers, such as lung cancer, brain cancer, and leukemias, not served by immune checkpoint inhibitors. Their approach targets the thematic pathway in cancer cells responsible for their growth and proliferation. In their drug development, AI an…

1
Cancer Molecular Profiling Using Next-Generation Sequencing to Treat Rare Diseases with Sanjeev Redekar Apollomics 17:45

23d ago17:45

17:45

Sanjeev Redkar, Co-Founder, Executive Director, and President of Apollomics, focuses on difficult-to-treat cancers, such as lung cancer, brain cancer, and leukemias, not served by immune checkpoint inhibitors. Their approach targets the thematic pathway in cancer cells responsible for their growth and proliferation. In their drug development, AI an…

1
Redefining Healthcare for Women Over 65 with Kristen Helton Herself Health TRANSCRIPT

24d ago

—

Kristen Helton, CEO and Co-Founder of Herself Health, provides comprehensive primary care designed specifically for women over 65, considering the unique health challenges these women face. The emphasis is on the importance of addressing women's health beyond reproductive health and the need for tailored treatment and screening for conditions that …

1
Redefining Healthcare for Women Over 65 with Kristen Helton Herself Health 19:07

24d ago19:07

19:07

Kristen Helton, CEO and Co-Founder of Herself Health, provides comprehensive primary care designed specifically for women over 65, considering the unique health challenges these women face. The emphasis is on the importance of addressing women's health beyond reproductive health and the need for tailored treatment and screening for conditions that …

1
Best decks for NAIC ft. Joe Bernard/OmniPoke 52:54

24d ago52:54

52:54

0:00 Intros2:20 Dragapult ex13:00 Raging Bolt ex18:30 Miradon ex22:00 Lugia VSTAR32:00 Snorlax stall36:00 Gardy40:00 CharizardJoe: https://x.com/omni_joeTwitter: https://twitter.com/Mellow_MagikarpPodcast: https://twitter.com/LakeOfRagepodDiscord: https://discord.gg/SmbccF55xZTwitch: https://www.twitch.tv/mellow_magikarpSponsor: https://www.tableto…

1
Modifying Macrophages to Overcome Evasion by Cancer Cells and Educate Immune System with Robert Towarnicki SIRPant Immunotherapeutics TRANSCRIPT

29d ago

—

Robert Towarnicki, CEO and Co-founder of SIRPant Immunotherapeutics, discusses cancer-specific immunotherapy for aggressive tumors, the role macrophages play in the immune response to cancer, and how cancer cells can shut down this response. SIRPant Immunotherapeutics aims to modify macrophages by reducing SIRPα expression, triggering them to eat c…

1
Modifying Macrophages to Overcome Evasion by Cancer Cells and Educate Immune System with Robert Towarnicki SIRPant Immunotherapeutics 24:52

29d ago24:52

24:52

Robert Towarnicki, CEO and Co-founder of SIRPant Immunotherapeutics, discusses cancer-specific immunotherapy for aggressive tumors, the role macrophages play in the immune response to cancer, and how cancer cells can shut down this response. SIRPant Immunotherapeutics aims to modify macrophages by reducing SIRPα expression, triggering them to eat c…

1
Power of AI and Data Analytics to Improve Patient Safety Risk Management with Jeff Surges RLDatix TRANSCRIPT

1M ago

—

Jeff Surges, CEO of RLDatix, offers global cloud-based solutions for risk management, compliance management, and regulatory management in healthcare. To address patient safety, Jeff emphasizes the need for a collaborative workforce, data analytics, and AI. RLDatix uses technology to automate information gathering, facilitate incident reporting, and…

1
Power of AI and Data Analytics to Improve Patient Safety Risk Management with Jeff Surges RLDatix 17:39

1M ago17:39

17:39

Jeff Surges, CEO of RLDatix, offers global cloud-based solutions for risk management, compliance management, and regulatory management in healthcare. To address patient safety, Jeff emphasizes the need for a collaborative workforce, data analytics, and AI. RLDatix uses technology to automate information gathering, facilitate incident reporting, and…

1
Tailoring Diabetes Management Using Hybrid Closed-Loop Algorithm to Meet Individual Needs with Lou Lintereur Medtronic Diabetes TRANSCRIPT

1M ago

—

Lou Lintereur, Chief Engineer for automated delivery systems at Medtronic Diabetes, brought his knowledge from working as an aerospace engineer at NASA to developing technology for those living with diabetes. He introduces the MiniMed 780G, a closed-loop system that combines an insulin pump and continuous glucose monitor (CGM) with a control algori…

1
Tailoring Diabetes Management Using Hybrid Closed-Loop Algorithm to Meet Individual Needs with Lou Lintereur Medtronic Diabetes 20:01

1M ago20:01

20:01

Lou Lintereur, Chief Engineer for automated delivery systems at Medtronic Diabetes, brought his knowledge from working as an aerospace engineer at NASA to developing technology for those living with diabetes. He introduces the MiniMed 780G, a closed-loop system that combines an insulin pump and continuous glucose monitor (CGM) with a control algori…

1
Transparency in Coverage Rule Provides Precision of Price and Negotiated Rates for Healthcare with Mark Galvin TALON TRANSCRIPT

1M ago

—

Mark Galvin, Co-Founder, President, and CEO of TALON, discusses the Transparency in Coverage rule in healthcare, which was added to the Affordable Care Act and requires commercial health plan sponsors to provide transparency in the costs of tests, procedures, and other medical services. The rule aims to provide patients with information on pricing …

1
Transparency in Coverage Rule Provides Precision of Price and Negotiated Rates for Healthcare with Mark Galvin TALON 20:43

1M ago20:43

20:43

Mark Galvin, Co-Founder, President, and CEO of TALON, discusses the Transparency in Coverage rule in healthcare, which was added to the Affordable Care Act and requires commercial health plan sponsors to provide transparency in the costs of tests, procedures, and other medical services. The rule aims to provide patients with information on pricing …

1
Twilight Masquerade set review ft Regional Champ Tim Franklin 1:07:10

1M ago1:07:10

1:07:10

0:00 Intros 1:30 Who is Tim 5:30 Best cards 32:30 Dragapult Tim: https://x.com/TimDanklin Twitter: https://twitter.com/Mellow_Magikarp Podcast: https://twitter.com/LakeOfRagepod Discord: https://discord.gg/SmbccF55xZ Twitch: https://www.twitch.tv/mellow_magikarp Sponsor: https://www.tabletopvillage.com/Code: Mellow5 for 10% off Sponsor: https://tce…

1
Deploying Technology in Decentralized Clinical Trials Improves Recruitment and Retention with Alice Lin Tigermed Consulting TRANSCRIPT

1M ago

—

Alice Lin, DCT Solutions Director in the DCT Business Department of Tigermed Consulting, a global CRO, contract research organization, that provides biopharmaceutical and medical device companies with a range of services including digital technology to conduct decentralized clinical trials. Their approach focuses on patient-centricity, efficiency, …

1
Deploying Technology in Decentralized Clinical Trials Improves Recruitment and Retention with Alice Lin Tigermed Consulting 18:50

1M ago18:50

18:50

Alice Lin, DCT Solutions Director in the DCT Business Department of Tigermed Consulting, a global CRO, contract research organization, that provides biopharmaceutical and medical device companies with a range of services including digital technology to conduct decentralized clinical trials. Their approach focuses on patient-centricity, efficiency, …

1
Developing Drug Targeting B Cells in Autoimmune Disease of the Kidney IgA Nephropathy with Dr. Marshall Fordyce Vera Therapeutics TRANSCRIPT

1M ago

—

Dr. Marshall Fordyce, CEO and Founder of Vera Therapeutics, discusses the company's patient-centric approach to developing new medicines for autoimmune diseases. Vera is currently in Phase 3 with a molecule called Atacicept, which targets B cells in autoimmune diseases. They focus on IgA nephropathy, a rare kidney disease, and the third most common…

1
Developing Drug Targeting B Cells in Autoimmune Disease of the Kidney IgA Nephropathy with Dr. Marshall Fordyce Vera Therapeutics 20:09

1M ago20:09

20:09

Dr. Marshall Fordyce, CEO and Founder of Vera Therapeutics, discusses the company's patient-centric approach to developing new medicines for autoimmune diseases. Vera is currently in Phase 3 with a molecule called Atacicept, which targets B cells in autoimmune diseases. They focus on IgA nephropathy, a rare kidney disease, and the third most common…

1
Developing Drugs to Treat Rare Liver Diseases NASH PBC ACLF with Pascal Prigent GENFIT TRANSCRIPT

1M ago

—

Pascal Prigent, the CEO of GENFIT, a French biotech that has been working on liver diseases for about 20 years and has developed a compound called elafibranor for conditions such as primary biliary cholangitis (PBC). The company is also developing assets in acute-on-chronic liver failure (ACLF). He highlights the high unmet medical need in ACLF, wh…

Podcasts Worth a Listen

Brian Steffen Podcasts

Podcasts Worth a Listen

Quick Reference Guide